1 November 2024 false No description of principal activity Taxfiler 2024.6 07285425business:PrivateLimitedCompanyLtd2024-11-012025-10-31 072854252024-10-31 072854252024-11-012025-10-31 07285425business:AuditExemptWithAccountantsReport2024-11-012025-10-31 07285425business:FilletedAccounts2024-11-012025-10-31 072854252025-10-31 07285425business:Director12024-11-012025-10-31 07285425business:RegisteredOffice2024-11-012025-10-31 072854252024-10-31 07285425core:WithinOneYear2025-10-31 07285425core:WithinOneYear2024-10-31 07285425core:ShareCapitalcore:PreviouslyStatedAmount2025-10-31 07285425core:ShareCapitalcore:PreviouslyStatedAmount2024-10-31 07285425core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-10-31 07285425core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-10-31 07285425core:PreviouslyStatedAmount2025-10-31 07285425core:PreviouslyStatedAmount2024-10-31 07285425business:SmallEntities2024-11-012025-10-31 07285425countries:EnglandWales2024-11-012025-10-31 07285425core:AdditionsToInvestments2025-10-31 07285425business:Director112024-10-31 07285425business:Director112024-11-012025-10-31 07285425business:Director112025-10-31 072854252023-07-012024-10-31 iso4217:GBP xbrli:pure
Company Registration No. 07285425 (England and Wales)
Dna-Play Limited Unaudited accounts for the year ended 31 October 2025
Dna-Play Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Dna-Play Limited Company Information for the year ended 31 October 2025
Director
Jacek Maklakiewicz
Company Number
07285425 (England and Wales)
Registered Office
Unit 4C Main Road Bramfield Hertford SG14 2FD
Accountants
Optics Accounting Ltd Hampden House Monument Business Park Chalgrove OX44 7RW
- 3 -
Dna-Play Limited Statement of financial position as at 31 October 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Investments
4
399,667 
389,666 
Current assets
Debtors
5
112,498 
100,880 
Creditors: amounts falling due within one year
6
(68,226)
(36,717)
Net current assets
44,272 
64,163 
Net assets
443,939 
453,829 
Capital and reserves
Called up share capital
1,000 
1,000 
Profit and loss account
442,939 
452,829 
Shareholders' funds
443,939 
453,829 
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 20 July 2026 and were signed on its behalf by
Jacek Maklakiewicz Director Company Registration No. 07285425
- 4 -
Dna-Play Limited Notes to the Accounts for the year ended 31 October 2025
1
Statutory information
Dna-Play Limited is a private company, limited by shares, registered in England and Wales, registration number 07285425. The registered office is Unit 4C Main Road, Bramfield, Hertford, SG14 2FD.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention. These financial statements have been prepared on the basis that the company will continue to be a going concern. If this assumption is not considered to be valid then adjustments would need to be made to reduce the value of assets to their recoverable amount, to provide for any further liabilities that might arise, and to reclassify fixed assets and long term liabilities as current assets and current liabilities.
Presentation currency
The accounts are presented in £ sterling.
Investments
Investments in subsidiary undertakings are recognised at cost.
4
Investments
Subsidiary undertakings 
£ 
Valuation at 1 November 2024
389,666 
Additions
10,001 
Valuation at 31 October 2025
399,667 
5
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
Other debtors
112,498 
100,880 
6
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Bank loans and overdrafts
8,899 
9,430 
Amounts owed to group undertakings and other participating interests
37,039 
- 
Taxes and social security
22,288 
27,287 
68,226 
36,717 
- 5 -
Dna-Play Limited Notes to the Accounts for the year ended 31 October 2025
7
Loans to directors
Brought Forward 
Advance/ credit 
Repaid 
Carried Forward 
£ 
£ 
£ 
£ 
Jacek Maklakiewicz
75,425 
9,186 
500 
84,111 
75,425 
9,186 
500 
84,111 
During the period ending Oct 31, 2025, the company advanced £6,250 to the director and an interest of £2,936 on overdrawn DLA has been charged. The repayments during the year have amounted to £500. The loan is short-term and repayable on demand. The total balance of advances outstanding as at Oct 31, 2024 was £84,111.
8
Transactions with related parties
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.
9
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 6 -